{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Climb Bio, Inc."},"Symbol":{"label":"Symbol","value":"CLYM"},"Address":{"label":"Address","value":"20 WILLIAM STREET,SUITE 145 SUITE B221 NO. 125, WELLESLEY HILLS, Massachusetts, 02481, United States"},"Phone":{"label":"Phone","value":"1-866-857-2596"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Companys lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.eliemtx.com"},"KeyExecutives":{"label":"Key Executives","value":[]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}